REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN)

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class
Equity / COMMON STOCK
Shares outstanding
104,986,330
Total 13F shares
72,762,550
Share change
+1,171,361
Total reported value
$29,238,474,482
Put/Call ratio
113%
Price per share
$402.02
Number of holders
543
Value change
+$503,682,119
Number of buys
237
Number of sells
253

Institutional Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q3 2016

As of 30 Sep 2016 REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) had 543 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 72,762,550 shares of stock of the company.
Largest 10 holders included FMR LLC, Capital World Investors, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, STATE STREET CORP, SANDS CAPITAL MANAGEMENT, LLC, BlackRock Fund Advisors, JENNISON ASSOCIATES LLC, BlackRock Institutional Trust Company, N.A., and Artisan Partners Limited Partnership.
This table shows 543 institutional shareholders of the security as of 30 Sep 2016.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.